C. Rangger Et Al. , "Design and Evaluation of Novel Radiolabelled VIP Derivatives for Tumour Targeting," ANTICANCER RESEARCH , vol.33, no.4, pp.1537-1546, 2013
Rangger, C. Et Al. 2013. Design and Evaluation of Novel Radiolabelled VIP Derivatives for Tumour Targeting. ANTICANCER RESEARCH , vol.33, no.4 , 1537-1546.
Rangger, C., Helbok, A., Ocak, M., Radolf, T., Andreae, F., Virgolini, I. I., ... Von Guggenberg, E.(2013). Design and Evaluation of Novel Radiolabelled VIP Derivatives for Tumour Targeting. ANTICANCER RESEARCH , vol.33, no.4, 1537-1546.
Rangger, Christine Et Al. "Design and Evaluation of Novel Radiolabelled VIP Derivatives for Tumour Targeting," ANTICANCER RESEARCH , vol.33, no.4, 1537-1546, 2013
Rangger, Christine Et Al. "Design and Evaluation of Novel Radiolabelled VIP Derivatives for Tumour Targeting." ANTICANCER RESEARCH , vol.33, no.4, pp.1537-1546, 2013
Rangger, C. Et Al. (2013) . "Design and Evaluation of Novel Radiolabelled VIP Derivatives for Tumour Targeting." ANTICANCER RESEARCH , vol.33, no.4, pp.1537-1546.
@article{article, author={Christine Rangger Et Al. }, title={Design and Evaluation of Novel Radiolabelled VIP Derivatives for Tumour Targeting}, journal={ANTICANCER RESEARCH}, year=2013, pages={1537-1546} }